查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1836307

癌症活检市场，按产品、按类型、按应用、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Cancer Biopsy Market, By Product, By Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 388 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年癌症切片市场规模价值 322.6812 亿美元，2025 年至 2032 年的复合年增长率为 8.23%。

癌症活检是一种用于诊断癌症的医疗程序，透过从身体可疑部位取出少量组织、体液或细胞样本进行实验室检查。此检查有助于确定癌症的存在、类型和分期，并指导医生製定合适的治疗方案。根据异常部位，活检可以采用不同的方法进行，例如针吸活检、手术活检或内视镜活检。

癌症切片市场-市场动态

全球癌症盛行率不断上升，推动市场需求

全球癌症切片市场受全球癌症盛行率急剧上升的驱动。世界卫生组织 (WHO) 的数据显示，2022 年全球新增癌症病例近 2,000 万例，凸显了诊断解决方案的迫切性。各国政府和卫生机构都强调早期发现，这直接刺激了活检需求。然而，液体活检和新一代定序等先进技术仍然成本高昂，限制了中低收入国家对这些技术的使用。

在机会方面，液体活检的应用正在加速：美国食品药物管理局 (FDA) 已批准 40 多种用于靶向癌症治疗的伴随诊断产品，确保更广泛的临床整合。此外，诸如美国「癌症登月计画」和欧盟「战胜癌症计画」等大规模政府措施正在大幅增加对癌症研究和创新的资助。这些因素共同创造了一个市场格局：不断上升的发病率和支持性政策超过了成本挑战，从而确保了全球癌症治疗的持续成长。

癌症切片市场-細項分析：

全球癌症活检市场根据产品、类型、应用、最终用户和地区进行细分。

市场依产品分为三类：服务、仪器以及试剂盒、耗材。预计在预测期内，服务领域将占据主要市场份额，这得益于全球范围内对先进诊断检测、病理学服务的需求不断增长，以及微创活检程序的日益普及。

根据应用，市场分为十二类：乳癌、子宫颈癌、大肠癌、摄护腺癌、肺癌、血癌、皮肤癌、肾癌、卵巢癌、胰臟癌、肝癌等。其中，乳癌预计将在预测期内占据最大的市场份额，这得益于其高盛行率、筛检项目的不断增加以及先进诊断技术的日益普及。

癌症活检市场——地理洞察

北美癌症切片市场占据全球市场主导地位，份额超过40%。高发病率和强有力的政策框架进一步巩固了该地区的领先地位。根据美国癌症统计数据，2022年报告了279,731例女性乳癌新病例，癌症总发生率持续逐年上升。

新一代定序的医保覆盖以及FDA对液体活检检测（例如Guardant360 CDx）的批准，进一步加速了液体活检的普及。在欧洲，欧盟抗癌计画旨在确保2025年90%的符合资格的公民能够接受筛检，而英国国民医疗服务体系（NHS England）则扩大了液体活检试点项目，以提高早期诊断水平。亚太地区是成长最快的市场：印度ICMR预测2024年将新增153万例病例，日本报告2022年将新增约101万例病例，这两个地区都显着扩大了活检需求。总体而言，政策支持、报销透明度以及病例数量的增长使北美保持领先地位，而欧洲和亚太地区则迅速缩小差距。

癌症切片市场-竞争格局：

随着对早期精准癌症诊断的需求日益增长，各公司正致力于提升活检解决方案的创新和效率。市场参与者正致力于开发微创活检技术，整合先进的影像引导技术，并提升分子检测能力以提高精准度。各公司正与研究机构和医疗保健机构进行策略合作，以拓展临床应用。此外，各公司正在投资自动化、数位病理学和人工智慧诊断技术，以加速获得结果、提高准确性并获得竞争优势。

目录

第 1 章：癌症活检市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 癌症切片市场产品片段
    • 癌症活检市场片段（按类型）
    • 癌症切片市场片段（按应用）
    • 癌症活检市场片段（按最终用户）
    • 癌症活检市场（按国家/地区）
    • 癌症活检市场（按地区）
  • 竞争洞察

第三章：癌症切片关键市场趋势

  • 癌症切片市场驱动因素
    • 市场驱动因素的影响分析
  • 癌症切片市场限制
    • 市场限制的影响分析
  • 癌症切片市场机会
  • 癌症切片市场未来趋势

第四章：癌症活检产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：癌症切片市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：癌症切片市场格局

  • 2024年癌症切片市场份额分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：癌症切片市场－按产品

  • 概述
    • 按产品细分市场占有率分析
    • 服务
    • 仪器
    • 套件和耗材

第 8 章：癌症活检市场 - 按类型

  • 概述
    • 按类型细分市场占有率分析
    • 液体活检
      • 芯针切片（CNB）
      • 细针抽吸（FNA）
    • 组织切片
      • 手术切片
      • 针吸切片
    • 其他的

第九章：癌症切片市场－按应用

  • 概述
    • 按应用细分市场占有率分析
    • 乳癌
    • 子宫颈癌
    • 大肠直肠癌
    • 摄护腺癌
    • 肺癌
    • 血癌
    • 皮肤癌
    • 肾癌
    • 卵巢癌
    • 胰腺癌
    • 肝癌
    • 其他的

第 10 章：癌症活检市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 诊断中心
    • 癌症研究中心
    • 研究与学术

第 11 章：癌症活检市场 - 按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美癌症切片主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲癌症切片检查主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区（APAC）
    • 概述
    • 亚太地区癌症切片主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品）
    • 亚太地区市场规模及预测（按类型）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲癌症活检主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品）
    • 拉丁美洲市场规模及预测（按类型）
    • 拉丁美洲市场规模及预测（按应用）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲癌症活检主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品）
    • MEA 市场规模和预测（按类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章：癌症活检产业主要供应商分析

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • QIAGEN
    • ANGLE plc
    • Illumina, Inc.
    • BD (Becton, Dickinson and Company)
    • Hologic, Inc.
    • Myriad Genetics, Inc.
    • Biocept, Inc.
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GRAIL, Inc.
    • Lucence Health Inc.
    • Guardant Health Inc.
    • Freenome Holdings, Inc.
    • Exact Sciences Corporation
    • Biodesix (Integrated Diagnostics)
    • Epigenomics AG
    • Oncimmune
    • HelioHealth (Laboratory for Advanced Medicine)
    • Chronix Biomedical, Inc.
    • Genesystems, Inc. (Genesys Biolabs)
    • Personal Genome Diagnostics Inc.
    • Personalis Inc.
    • Natera, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5676

Cancer biopsy market size was valued at US$ 32,268.12 Million in 2024, expanding at a CAGR of 8.23% from 2025 to 2032.

A cancer biopsy is a medical procedure used to diagnose cancer by removing a small sample of tissue, fluid, or cells from a suspicious area in the body for laboratory examination. This test helps determine the presence, type, and stage of cancer, guiding doctors in creating appropriate treatment plans. Biopsies can be performed using different methods such as needle biopsy, surgical biopsy, or endoscopic biopsy, depending on the location of the abnormality.

Cancer Biopsy Market- Market Dynamics

Increasing prevalence of cancer among people globally to propel market demand

The global cancer biopsy market is driven by the sharp rise in cancer prevalence worldwide. According to the World Health Organization (WHO), nearly 20 million new cancer cases were recorded in 2022, highlighting the urgency for diagnostic solutions. Governments and health agencies are emphasizing early detection, which directly fuels biopsy demand. However, advanced techniques such as liquid biopsy and next-generation sequencing remain costly, restricting access in low- and middle-income countries.

On the opportunity side, liquid biopsy adoption is accelerating: the U.S. Food and Drug Administration (FDA) has already approved more than 40 companion diagnostics for targeted cancer therapies, ensuring wider clinical integration. Additionally, large-scale government initiatives-such as the U.S. Cancer Moonshot program and the European Union's Beating Cancer Plan-are significantly boosting funding for cancer research and innovation. These combined forces create a market landscape where rising incidence and supportive policy outweigh cost challenges, ensuring sustained global growth.

Cancer Biopsy Market- Segmentation Analysis:

The Global Cancer Biopsy Market is segmented on the basis of Product, Type, Application, End User, and Region.

The market is divided into three categories based on Product: services, instruments, and kits & consumables. The services segment is expected to hold the major market share during the forecast period, driven by rising demand for advanced diagnostic testing, pathology services, and increasing adoption of minimally invasive biopsy procedures worldwide.

The market is divided into twelve categories based on Application: breast cancer, cervical cancer, colorectal cancer, prostate cancer, lung cancer, blood cancer, skin cancer, kidney cancer, ovarian cancer, pancreatic cancer, liver cancer, and others. Among these, the breast cancer segment is expected to hold the largest market share during the forecast period, driven by its high prevalence, rising screening programs, and growing adoption of advanced diagnostic techniques

Cancer Biopsy Market- Geographical Insights

North America cancer biopsy market dominated the global market with over 40% share. The region's lead is reinforced by high incidence rates and strong policy frameworks. According to U.S. Cancer Statistics, 279,731 new female breast cancer cases were reported in 2022, and total cancer incidence continues to rise year-on-year.

Medicare coverage for next-generation sequencing and FDA approvals of liquid biopsy tests, such as Guardant360 CDx, further accelerate adoption. In Europe, the EU Beating Cancer Plan aims to ensure 90% of eligible citizens are offered screening by 2025, while NHS England has expanded liquid biopsy pilots to improve early diagnosis. Asia Pacific is the fastest-growing market: India's ICMR projects 1.53 million new cases in 2024, and Japan reported around 1.01 million new cases in 2022, both significantly expanding biopsy demand. Collectively, policy backing, reimbursement clarity, and rising case volumes sustain North America's lead while Europe and Asia Pacific rapidly close the gap.

Cancer Biopsy Market- Competitive Landscape:

Rising demand for early and accurate cancer diagnosis is driving companies to enhance innovation and efficiency in biopsy solutions. Market participants are focusing on developing minimally invasive biopsy techniques, integrating advanced imaging guidance, and improving molecular testing capabilities to increase precision. Strategic collaborations with research institutions and healthcare providers are being pursued to expand clinical applications. In addition, companies are investing in automation, digital pathology, and AI-powered diagnostics to accelerate results, strengthen accuracy, and gain a competitive advantage.

Recent Developments:

In April 2025, Labcorp launched molecular residual disease and liquid biopsy testing, offering advanced genomic insights to support personalized cancer treatment, improve disease monitoring, and aid in early relapse detection for better patient outcomes across diverse cancer types.

In June 2025, M42 announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to introduce advanced liquid biopsy testing in the UAE, enhancing cancer diagnosis, treatment decisions, and biomarker testing for improved precision oncology outcomes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CANCER BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • QIAGEN
  • ANGLE plc
  • Illumina, Inc.
  • BD (Becton, Dickinson and Company)
  • Hologic, Inc.
  • Myriad Genetics, Inc.
  • Biocept, Inc.
  • Danaher
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GRAIL, Inc.
  • Lucence Health Inc.
  • Guardant Health Inc.
  • Freenome Holdings, Inc.
  • Exact Sciences Corporation
  • Biodesix (Integrated Diagnostics)
  • Epigenomics AG
  • Oncimmune
  • HelioHealth (Laboratory for Advanced Medicine)
  • Chronix Biomedical, Inc.
  • Genesystems, Inc. (Genesys Biolabs)
  • Personal Genome Diagnostics Inc.
  • Personalis Inc.
  • Natera, Inc.
  • Others

GLOBAL CANCER BIOPSY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Services
  • Instruments
  • Kits & Consumables

GLOBAL CANCER BIOPSY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Liquid Biopsies
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration (FNA)
  • Tissue Biopsies
  • Surgical Biopsies
  • Needle Biopsies
  • Others

GLOBAL CANCER BIOPSY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Lung Cancer
  • Blood Cancer
  • Skin Cancer
  • Kidney Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Liver Cancer
  • Others

GLOBAL CANCER BIOPSY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Centers
  • Cancer Research Centers
  • Research & Academics

GLOBAL CANCER BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cancer Biopsy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cancer Biopsy Market Snippet by Product
    • 2.1.2. Cancer Biopsy Market Snippet by Type
    • 2.1.3. Cancer Biopsy Market Snippet by Application
    • 2.1.4. Cancer Biopsy Market Snippet by End User
    • 2.1.5. Cancer Biopsy Market Snippet by Country
    • 2.1.6. Cancer Biopsy Market Snippet by Region
  • 2.2. Competitive Insights

3. Cancer Biopsy Key Market Trends

  • 3.1. Cancer Biopsy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cancer Biopsy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cancer Biopsy Market Opportunities
  • 3.4. Cancer Biopsy Market Future Trends

4. Cancer Biopsy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cancer Biopsy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cancer Biopsy Market Landscape

  • 6.1. Cancer Biopsy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cancer Biopsy Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Services
    • 7.1.3. Instruments
    • 7.1.4. Kits & Consumables

8. Cancer Biopsy Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. Liquid Biopsies
      • 8.1.2.1. Core Needle Biopsy (CNB)
      • 8.1.2.2. Fine Needle Aspiration (FNA)
    • 8.1.3. Tissue Biopsies
      • 8.1.3.1. Surgical Biopsies
      • 8.1.3.2. Needle Biopsies
    • 8.1.4. Others

9. Cancer Biopsy Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Cervical Cancer
    • 9.1.4. Colorectal Cancer
    • 9.1.5. Prostate Cancer
    • 9.1.6. Lung Cancer
    • 9.1.7. Blood Cancer
    • 9.1.8. Skin Cancer
    • 9.1.9. Kidney Cancer
    • 9.1.10. Ovarian Cancer
    • 9.1.11. Pancreatic Cancer
    • 9.1.12. Liver Cancer
    • 9.1.13. Others

10. Cancer Biopsy Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Centers
    • 10.1.4. Cancer Research Centers
    • 10.1.5. Research & Academics

11. Cancer Biopsy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cancer Biopsy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cancer Biopsy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cancer Biopsy Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Cancer Biopsy Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Cancer Biopsy Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cancer Biopsy Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. QIAGEN
    • 12.2.2. ANGLE plc
    • 12.2.3. Illumina, Inc.
    • 12.2.4. BD (Becton, Dickinson and Company)
    • 12.2.5. Hologic, Inc.
    • 12.2.6. Myriad Genetics, Inc.
    • 12.2.7. Biocept, Inc.
    • 12.2.8. Danaher
    • 12.2.9. Thermo Fisher Scientific, Inc.
    • 12.2.10. F. Hoffmann-La Roche Ltd.
    • 12.2.11. GRAIL, Inc.
    • 12.2.12. Lucence Health Inc.
    • 12.2.13. Guardant Health Inc.
    • 12.2.14. Freenome Holdings, Inc.
    • 12.2.15. Exact Sciences Corporation
    • 12.2.16. Biodesix (Integrated Diagnostics)
    • 12.2.17. Epigenomics AG
    • 12.2.18. Oncimmune
    • 12.2.19. HelioHealth (Laboratory for Advanced Medicine)
    • 12.2.20. Chronix Biomedical, Inc.
    • 12.2.21. Genesystems, Inc. (Genesys Biolabs)
    • 12.2.22. Personal Genome Diagnostics Inc.
    • 12.2.23. Personalis Inc.
    • 12.2.24. Natera, Inc.
    • 12.2.25. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us